About Gufic BioSciences Ltd
Gufic BioSciences engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Founded
1984
CEO
Jayesh P Choksi
Employees
2,903
HQ
Mumbai, India
Finished Products
1Sale of Products
₹2,324.35Cr2Other Operating Revenues
₹179.08Cr3Processing Charges
₹63.51CrRaw Materials
1Raw Material Consumed
₹1,403.89Cr2Purchases of Finished Goods
₹122.79Cr3Other Purchases
₹55.41Cr4Packing materials
₹36.36Cr5Purchases of Stock in Trade
₹25.84CrAbout Gufic BioSciences Ltd
Gufic BioSciences engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Founded:1984
CEO:Jayesh P Choksi
Employees:2,903
HQ:Mumbai, India
Finished Products
1Sale of Products
₹2,324.35Cr2Other Operating Revenues
₹179.08Cr3Processing Charges
₹63.51CrRaw Materials
1Raw Material Consumed
₹1,403.89Cr2Purchases of Finished Goods
₹122.79Cr3Other Purchases
₹55.41Cr4Packing materials
₹36.36Cr5Purchases of Stock in Trade
₹25.84CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹454
52W Low
₹268
Volume693.83K
Avg VolumeN/A
Beta0.63
Dividend Yield0.02%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
60.01x
Valuation
P/B Ratio
6.62x
Valuation
EPS
₹7.32
Valuation
Dividend Yield
0.02%
Valuation
ROE
9.66%
Profitability
ROCE
11.45%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical and related productsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
77.0%
International
23.0%
In India77.0%
Europe9.5%
Asia6.9%
North America3.4%
Africa2.8%
South America0.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.61x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.